当研究室(遺伝子治療・再生医学分野)では、再生医療、遺伝子治療、バイオテクノロジーと先端医学開発の研究を行っています。

論文 - 鹿児島大学大学院医歯学総合研究科 先進治療科学専攻 運動機能修復学講座 遺伝子治療・再生医学分野

ico treatise

Ijichi N, Ikeda K, Fujita M, Usui T, Urano T, Azuma K, Ouchi Y, Horie-Inoue K, and Inoue S.
EPAS1, a dexamethasone-inducible gene in osteoblasts, inhibits osteoblastic differentiation.

 

The Open Bone Journal. 1: 28-37, 2009

 


 

bba

Kubo M, Ijichi N, Ikeda K, Horie-Inoue K, Takeda S, and Inoue S.
Modulation of adipogenesis-related gene expression by estrogen-related receptor γ during adipocytic differentiation.

 

Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms.1789: 71-77, 2009

 


 

am j physiol heart circ physiolgifLi L, Okada H, Takemura G, Kosai K, Kanamori H, Esaki M, Takahashi T, Goto K, Tsujimoto A, Maruyama R, Kawamura I, Kawaguchi T, Takeyama T, Fujiwara T, Fujiwara H, Minatoguchi S.

Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction.

 

Am J Physiol Heart Circ Physiol. 97(4):H1504-13. 2009

  


 

ico treatiseUmeno H, Chitose S, Murofushi Y, Kosai K, Sato K, Kawahara A, Nakashima T.

Efficacy of autologous fat injection laryngoplasty with an adenoviral vector expressing hepatocyte growth factor in a canine model.

 

J Laryngol Otol ;123,31:24-9. 2009

 


 

ajpheart.2009.296.issue 3.coverOkada H, Takemura G, Kosai K, Tsujimoto A, Esaki M, Takahashi T, Nagano S, Kanamori H, Miyata S,Li Y, Ohno T, Maruyama R, Ogino A, Li L, Nakagawa M, Nagashima K, Fujiwara T, Fujiwara H, Minatoguchi S.

Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.

 

Am J Physiol Heart Circ Physiol. 296(3):H616-26. 2009

 


 

ico treatiseKondo T, Takemura G, Kosai K, Ohno T, Takahashi T, Esaki M, Goto K, Maruyama R, Murata I, Minatoguchi S, Fujiwra T, Fujiwara H.

Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.

 

Clin Exp Pharmacol Physiol. 35(11):1288-93. 2008

 


 

ajpheart.2008.294.issue 2.coverEsaki M, Takemura G, Kosai K, Takahashi T, Miyata S, Li L, Goto K, Maruyama R, Okada H, Kanamori H, Ogino A, Ushikoshi H, Minatoguchi S, Fujiwara T, Fujiwara H.

Treatment with an adenoviral vector encoding hepatosyte growth factor mitigates established cardiac dysfunction in doxorubicin –induced cardiomyopathy.

 

Am J Physiol Heart Circ Physiol. 294(2): H1048-1057, 2008

 


 

pnasSuzuki K, Mitsui K, Aizawa E, Hasegawa K, Kawase E, Yamagishi T, Shimizu Y, Suemori H, Nakatsuji N, Mitani K.

Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors.

 

Proc Natl Acad Sci USA.105 13781-6. 2008

 


 

bbrc2007

Ijichi N, Ikeda K, Horie-Inoue K, Yagi K, Okazaki Y, and Inoue S.
Estrogen-related receptor α modulates the expression of adipogenesis-related genes during adipocyte differentiation.

 

Biochem Biophys Res Commun. 358: 813-818, 2007

 


 

 

j card failgif Chen XH, Minatoguchi S, Kosai K, Yuge K, Takahashi T, Arai M, Wang N,
 Misao Y, Lu C, Onogi H, Kobayashi H, Yasuda S, Ezaki M, Ushikoshi H,
 Takemura G, Fujiwara T, Fujiwara H.

 In vivo hepatocyte growth factor gene transfer reduces myocardial
 ischemiareperfusion injury through its multiple actions.

 

                         J Card Fail. 13(10):874-883, 874-883, 2007

  


 

業績・特許・研究費

大学院生・スタッフ募集

https://oncolo.jp/ct/ad/ad0038

鹿児島大学大学院医歯学総合研究科 遺伝子治療・再生医学分野

医学部基礎研究棟3階
(エレベーターを出てから左の教室です)

鹿児島県鹿児島市桜ヶ丘8丁目35-1
TEL.099-275-5219
FAX.099-265-9721

このページのTOPへ